The estimated Net Worth of John J Toole is at least $3.87 Million dollars as of 25 April 2007. John Toole owns over 19,148 units of Gilead Sciences stock worth over $1,549,839 and over the last 21 years John sold GILD stock worth over $2,319,388.
John has made over 16 trades of the Gilead Sciences stock since 2003, according to the Form 4 filled with the SEC. Most recently John exercised 19,148 units of GILD stock worth $260,413 on 25 April 2007.
The largest trade John's ever made was exercising 57,900 units of Gilead Sciences stock on 2 May 2005 worth over $352,611. On average, John trades about 13,855 units every 47 days since 2003. As of 25 April 2007 John still owns at least 19,148 units of Gilead Sciences stock.
You can see the complete history of John Toole stock trades at the bottom of the page.
John's mailing address filed with the SEC is 333 LAKESIDE DRIVE, , FOSTER CITY, CA, 94404.
Over the last 21 years, insiders at Gilead Sciences have traded over $221,090,692 worth of Gilead Sciences stock and bought 30,121 units worth $1,879,767 . The most active insiders traders include John C Martin, Norbert W Bischofberger, and John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of $3,341,365. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth $51,721.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: